Citations

Clear

13603 citation(s) found for "_, _".

Chlorhexidine gluconate application, diabetes, revision surgery, and extended operative time increase risk for penile implant infection
Hashemi, Milad Bonakdar , Ziegelmann, Matthew , Lybbert, Daniel, Piraino, Javier , Lozoya, Andres H Guillen, Köhler, Tobias , Helo, Sevann , Bonakdar Hashemi, Milad, Ziegelmann, Matthew J, Lybbert, Daniel T, Piraino, Javier , Guillen Lozoya, Andres H

Mayo Clinic

The Journal of Sexual Medicine | January 20, 2025 | Volume: 22 | Issue: 3 | Pages: 508-516

10.1093/jsxmed/qdaf009 | PMID 39916374 Get It

Abstract Background Chlorhexidine gluconate (CHG) (0.05%) has recently been suggested as a dip and irrigation solution at time of inflatable penile prosthesis (IPP) surgery. Aim This study evaluated infection rates before and after implementing CHG protocol while investigating concurrent risk factors contributing to post operative infections. Methods A retrospective, consecutive cohort study was performed that included patients who underwent insertion of a Coloplast Titan IPP including both virgin and revision cases between 2021 and 2024. Cases performed from January 2021 to August 2022 utilized rifampin/gentamicin for dip and vancomycin/gentamicin for irrigation (ABX), whereas those from October 2022 to May 2024 utilized CHG for both dip and irrigation. Perioperative risk factors including dip and irrigation solution used at time of surgery were compared between groups. Outcomes We defined the incidence of postoperative infection and risk factors associated with infection in each group. Results The incidence of infection was significantly higher in the 0.05% CHG group (13/377) compared to the ABX group (0/320) (P < .001). When analyzed separately by subgroup, virgin cases treated with CHG for dip and irrigation demonstrated a significantly higher infection rate (7/315) compared to those in the ABX group (0/280) (P = .012). Similarly, in revision cases, the CHG group also exhibited a significantly higher infection rate (0/40) than the ABX group (6/62) (P = .043). Univariable analysis of the CHG cohort identified three significant risk factors for infection: diabetes mellitus (DM), extended operative time (OP), and revision surgery (P = .003, .001, and < .001, respectively). Multivariable regression analysis revealed that patients with DM had a 5.7-fold increased risk of infection (OR: 5.70, P = .004), while those undergoing revision surgery faced a 5.3-fold higher risk (OR: 5.26, P = .004). Additionally, each minute increase in OP was associated with a 1% higher infection risk (OR: 1.01 per minute, P = .007). These associations remained significant after adjusting for all variables in the model. Clinical Implications Prosthetic surgeons should be cautious about adopting 0.05% CHG for both dip and irrigation in the absence of strong clinical evidence demonstrating its non-inferiority to antibiotic solutions. Strengths and Limitations This is the first clinical study reporting infection rates after IPP surgery using 0.05% CHG for both dip and irrigation. While retrospective and non-randomized, we present a relatively large sample size of patients. Conclusions Our findings identify four risk factors for penile prosthesis infection: usage of the 0.05% CHG solution for dip and irrigation solution of Coloplast hydrophilic-coated devices, DM, revision surgery, and extended OP.
Prenatal Care of Parents Who Continued Pregnancies With Down Syndrome, 2003–2022
Artal, Jonathan M. , Randall, Lindsey D. , Rubeck, Sabina , Allyse, Megan , Michie, Marsha , Riggan, Kirsten A. , Meredith, Stephanie , Skotko, Brian G. , Randall, Lindsey , Allyse, Megan A , Skotko, Brian G , Riggan, Kirsten A

Mayo Clinic

American Journal of Medical Genetics Part A | January 20, 2025 | Volume: 197 | Issue: 5 | Pages: No page available

10.1002/ajmg.a.63981 | PMID 39829122 Get It

ABSTRACTParents of children with Down syndrome have historically reported poor experiences receiving a prenatal diagnosis. In a 2003 survey, mothers reported that their physicians pitied them, emphasized negative aspects of Down syndrome, and encouraged them to terminate the pregnancy. This study assesses whether parents' perceptions have since improved. Community‐based organizations that had distributed the original 2003 survey distributed a similar survey to parents who have had a child with Down syndrome since 2003. Compared to the 2003 survey, parents continued to report dissatisfaction with their prenatal medical care (N = 60). Though subgroups became likelier to view their testing experience positively, parents' experiences worsened on certain metrics. Most parents reported dissatisfaction when providers conveyed pity or attempted to influence their decision‐making about the pregnancy. Interventions to date have failed to improve parents' perceptions of their prenatal medical support, urging new strategies to improve parents' care.
Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae
Thakolwiboon, Smathorn , Gilligan, Michael , Orozco, Emma, Dubey, Divyanshu , López‐Chiriboga, A. Sebastian , Valencia-Sánchez, Cristina , Zalewski, Nicholas L. , Ζεκερίδου, Αναστασία , Pittock, Sean J. , Dubey, Divyanshu , Pittock, S J , Flanagan, E P , Valencia Sanchez, Cristina , Zekeridou, Anastasia , McKeon, Andrew , Dubey, Divyanshu , Gilligan, Michael , Thakolwiboon, Smathorn , Britton, Jeffrey W. , Flanagan, Eoin P. , Smith, Kelsey M. , McKeon, Andrew

Mayo Clinic

Journal of Neurology, Neurosurgery & Psychiatry | January 20, 2025 | Volume: 96 | Issue: 8 | Pages: 736-743

10.1136/jnnp-2024-334957 | PMID 39832911 Get It

Background Data regarding long-term recovery from autoimmune encephalitis (AE) remain limited. Methods This retrospective observational study investigated outcomes in 182 patients who met the 2016 criteria for definite AE. Recovery data were available in 172 patients. Follow-up data at ≥24 months post-attack were available for 119. Recovery trajectory, residual symptoms, outcome predictors and causes of post-AE death were assessed. Results Of 172 patients, 138 (80%) achieved good recovery (modified Rankin Scale (mRS) ≤2) with a median recovery time of 4 months (95% CI: 2 to 6 months). Recovery varied by associated neural antibody, with the best recovery observed in leucine-rich glioma-inactivated 1 (97% good recovery, median recovery time 0 (0 to 2) months). Paraneoplastic AE (p=0.007), severe attacks (eg, mRS ≥4 at attack, p=0.007) and cerebrospinal fluid pleocytosis (p=0.005) were associated with a lower likelihood of good recovery, while seizure presentation (p=0.026) was associated with better recovery. Despite good recovery, several residual symptoms persisted ≥24 months post-AE, including cognitive deficits (53%), seizures (26%), depression (23%), sleep disorders (25%), brainstem/cerebellar symptoms (13%), other movement disorders (14%) and autonomic symptoms (12%). Predictors of long-term sequelae included disabling cognitive deficit at onset and delayed immunotherapy for post AE-dementia, and medial temporal atrophy as well as escalation to cyclophosphamide therapy for both drug-resistant epilepsy and chronic depression. Of 182 patients, 20 (11%) died; the most common cause of death was progression of AE (6/20 (30%)). Conclusion While the majority of patients achieved functional independence after AE, several residual symptoms persisted. Several clinical and paraclinical features were associated with long-term sequelae.
Artificial intelligence and transfusion education, research and practice: The view from the ISBT Clinical Transfusion Working Party
Al‐Riyami, Arwa Z. , Gammon, Richard R. , Seheult, Jansen N. , Arora, Satyam , Goel, Ruchika , Seheult, Jansen, Goel, Ruchika , Gammon, Richard R , Seheult, Jansen N , Arora, Satyam

Mayo Clinic

Vox Sanguinis | January 19, 2025 | Volume: 121 | Issue: 4 | Pages: 481-487

10.1111/vox.13793 | PMID 39828246 Get It

Abstract Background and Objectives Artificial intelligence (AI) has been gaining increasing interest in healthcare. During the 2024 International Society of Blood Transfusion (ISBT) Congress, the Clinical Transfusion Working Party (CTWP) conducted a session to explore the exciting intersection of AI in transfusion medicine (TM) practice, education and research. We report here the potential applications and the session outcome. Materials and Methods A pre‐workshop survey explored the participants' demographics and areas of use of AI and whether they have had any AI‐specific training or education. The workshop included presentations on the regulatory aspects of AI use and its application in TM practice, education and research. These were followed by round‐table discussions to explore participants' experience and concerns. Results The workshop had 72 attendees, with 38% falling in the 36–45‐year age group. A total of 70% indicated the use of AI, but only 12% reported having specific training or education. Participants expressed interest in different potential applications but also shared concerns on over‐reliance, potential loss of skills, the accuracy of provided information and content plagiarism. Conclusion The findings of the workshop highlight the need for training, educational resources, standards and regulatory frameworks to guide the use of AI tools in the field of TM.
Upper cervical spinal cord atrophy in MS: Sex, menopause, and neurodegeneration
Zeydan, Burcu , Son, Jiye , Neyal, Nur , Schwarz, Christopher G. , Atkinson, Elizabeth J. , Nathoo, Nabeela , Kantarci, Kejal , Port, John D. , Kantarci, Orhun H. , Morrison, Holly A, Nathoo, Nabeela , Flanagan, E P , Port, John D , Schwarz, Christopher G , Kantarci, Kejal , Zeydan, Burcu , Morrison, Holly A, Flanagan, Eoin P.

Mayo Clinic

Multiple Sclerosis Journal | January 18, 2025 | Volume: 31 | Issue: 3 | Pages: 278-289

10.1177/13524585241311441 | PMID 39825669 Get It

Background: Spinal cord (SC) atrophy is a key imaging biomarker of progressive multiple sclerosis (MS). Progressive MS is more common in men and postmenopausal women. Objective: Investigate the impact of sex and menopause on SC measurements in persons with MS (pwMS). Methods: In pwMS and age- and sex-matched controls, upper cervical SC area from brain MRI (UCC brain ) was obtained. Impact of sex and menopause on UCC brain (adjusted for total intracranial volume) and its association with progression and disability, including MS functional composite (MSFC), were investigated. Results: UCC brain was smaller in pwMS ( n = 118, 51.4 ± 5.3 mm 2 ) than controls ( n = 118, 54.2 ± 4.4 mm 2 , p < 0.001) and inversely correlated with older age in pwMS ( r = −0.24, p = 0.010) but not in controls ( r = −0.025, p = 0.786). In 173 pwMS (413 brain MRIs), UCC brain was smaller in men (49.5 ± 5.9 mm 2 ) than women (51.6 ± 5.5 mm 2 , p = 0.001), postmenopausal women (49.4 ± 5.6 mm 2 ) than premenopausal women (52.9 ± 4.1 mm 2 , p < 0.001), and progressive (47.5 ± 5.6 mm 2 ) than relapsing MS (52.1 ± 5.2 mm 2 , p < 0.001). UCC brain also correlated with disease duration ( r = −0.39, p < 0.001), 9-hole peg test ( r = −0.26, p = 0.005), and severe ambulatory disability (Expanded Disability Status Scale ⩾6) ( r = −0.27, p < 0.001). Conclusion: UCC brain , a biomarker of progressive MS, is inversely associated with age, disease duration, male sex, and menopause, highlighting the potential impact of sex and hormones on neurodegeneration in MS.
Reevaluating Anti-Inflammatory Therapy: Targeting Senescence to Balance Anti-Cancer Efficacy and Vascular Disease
Casso-Chapa, Bernardo , Le, Nhat‐Tu , Palaskas, Nicolas L. , Nead, Kevin T. , Eutsey, Lydia P., Samanthapudi, Venkata Subrahman K, Osborn, Abigail M., Mejia, Gilbert, Hoang, O.N. , Herrmann, Joerg, Kirkland, James L. , Chini, Eduardo N. , Yusuf, Syed Wamique , Iliescu, Cezar , Lorenzi, Philip L. , Chau, Khanh , Mendoza, Keila Carolina Ostos , Schadler, Keri , Le, Nhat-Tu , Palaskas, Nicolas L , Nead, Kevin T , Lee, Jonghae , Mejia, Gilbert , Hoang, Oanh , Lin, Steven H , Deswal, Anita M , Wang, Guangyu , Kirkland, James L , Krishnan, Sunil , Wehrens, Xander H T , Yusuf, Syed Wamique , Iliescu, Cezar A , Jain, Abhishek , Burks, Jared K , Seeley, Erin , Lorenzi, Philip L , Chau, Khanh M , Ostos-Mendoza, Keila C , Grumbach, Isabella M , Brookes, Paul S , Hanssen, Nordin M J , de Winther, Menno P J , Yvan-Charvet, Laurent , Kotla, Sivareddy , Schadler, Keri , Abe, Jun-Ichi , González, Norma Alicia Vazquez, Osborn, Abigail M., Lee, Jonghae , Lin, Steven H. , Herrmann, Joerg, Wang, Guangyu , Wehrens, Xander H.T. , Winther, Menno P.J. de , Kotla, Sivareddy

Mayo Clinic

Arteriosclerosis, Thrombosis, and Vascular Biology | January 16, 2025 | Volume: 45 | Issue: 3 | Pages: 372-385

10.1161/atvbaha.124.319870 | PMID 39817327 Get It

Modulating immune function is a critical strategy in cancer and atherosclerosis treatments. For cancer, boosting or maintaining the immune system is crucial to prevent tumor growth. However, in vascular disease, mitigating immune responses can decrease inflammation and slow atherosclerosis progression. Anti-inflammatory therapy, therefore, presents a unique dilemma for cancer survivors: while it may decrease cardiovascular risk, it might also promote cancer growth and metastasis by suppressing the immune response. Senescence presents a potentially targetable solution to this challenge; senescence increases the risk of both cancer therapy resistance and vascular disease. Exercise, notably, shows promise in delaying this premature senescence, potentially improving cancer outcomes and lowering vascular disease risk post-treatment. This review focuses on the long-term impact of cancer therapies on vascular health. We underscore the importance of modulating senescence to balance cancer treatment’s effectiveness and its vascular impact, and we emphasize investigating the role of exercise-mediated suppression of senescence in improving cancer survivorship.
Venetoclax in combination with fludarabine, cytarabine, granulocyte colony stimulating factor, and idarubicin (FLAG-Ida) in patients with acute leukemia of ambiguous lineage and acute lymphoblastic leukemia
Tessier, Steven , Gangat, Naseema , Begna, Kebede H. , Saliba, Antoine N. , Mangoankar, Abhishek A., Patnaik, Mrinal M. , Al‐Kali, Aref , Alkhateeb, Hassan B. , Saliba, Antoine N. , Saliba, Antoine N , Alkhateeb, Hassan B , Saliba, Antoine N , McCullough, Kristen , Shah, Meera , Hogan, William J.

Mayo Clinic

Leukemia & Lymphoma | January 16, 2025 | Volume: 66 | Issue: 4 | Pages: 780-784

10.1080/10428194.2024.2443017 | PMID 39817316 Get It

Digital Mammography, Tomosynthesis, and Contrast-Enhanced Mammography: Intraindividual Comparison of Mean Glandular Dose for Screening Examinations
Sanders, Jeremiah , Pavlicek, William , Stefan, Wolfgang, Sanders, Jeremiah W , Hanson, James, Sharpe, Richard E. , Hanson, James , Patel, Bhavika

Mayo Clinic

American Journal of Roentgenology | January 15, 2025 | Volume: 224 | Issue: 3 | Pages: No page available

10.2214/ajr.24.32150 | PMID 39813603 Get It

Characterizing Vitamin K Refusal in Term Hospital-Born Infants in Minnesota, 2015–2019
George, Caroline , Evans, Michael D. , Peterson, Loralie J., Prekker, Frances L., Schulte, Anna , Hennum, Jesse L., Evans, Michael D , George, Caroline L S , Sidebottom, Abbey , Prekker, Frances L., Brumbaugh, Jane E.

Mayo Clinic

Hospital Pediatrics | January 15, 2025 | Volume: 15 | Issue: 2 | Pages: 149-157

10.1542/hpeds.2024-008002 | PMID 39813165 Get It

BACKGROUND AND OBJECTIVES Some Minnesota clinicians perceive that the incidence of prophylactic vitamin K refusal is increasing, yet the actual incidence and which populations are most likely to refuse is unknown. Our objective is to identify the incidence of vitamin K refusal and to characterize the maternal-newborn dyads with increased refusal rates. METHODS This retrospective multi-institution study analyzed vitamin K refusal in newborns born from 2015 to 2019. Maternal-newborn dyad delivery and community characteristics (language, religion, population size) were collected and analyzed by univariable and multivariable logistic regression. RESULTS Among 102 451 term infants, 1.3% did not receive intramuscular vitamin K. Refusal increased from 0.9% in 2015 to 1.6% by 2019 (P &lt; .0001). In multivariable analysis, factors associated with increased likelihood of refusal included female sex (odds ratio [OR] 1.22, 95% CI 1.09–1.36), exclusive human milk feeding at hospital discharge (OR 3.46, 95% CI 2.87–4.17), parity greater than 0 (OR ranging from 1.32 [95% CI 1.13–1.54] for parity of 1, to 3.70 [95% CI 2.80–4.90] for parity of 4), having a midwife at delivery (OR 1.70, 95% CI 1.45–2.01), public insurance (OR 1.84, 95% CI 1.60–2.12), and Russian language (OR 4.92, 95% CI 2.90–8.35). Some religious identities had higher refusal rates (ie, Pentecostal 7.0%, Baptist 3.3%). CONCLUSION In a cohort of Minnesota hospital-born infants, the incidence of vitamin K refusal increased between 2015 and 2019. We identified large populations (eg, public insurance, exclusive human milk feeding) and smaller discrete communities (eg, Russian, Pentecostal) with opportunities for increasing prophylactic vitamin K acceptance through targeted community conversations.
Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology
Blitzblau, Rachel , Aasi, Sumaira Z. , Alam, Murad, Amini, Arya , Bibee, Kristin , Bolotin, Diana, DiMaio, Dominick J. , Farma, Jeffrey M. , Ghosh, Karthik, Harms, Kelly L. , LeBoeuf, Nicole R. , Lukens, John N. , Manber, Susan, Mark, Lawrence A. , Medina, Theresa , Nehal, Kishwer S. , Paragh, György , Patel, Tejesh , Rich, Jason T. , Shaha, Ashok R. , Sharma, Bhavina, Sokumbi, Yemi, Thomas, Valencia D., Tomblinson, Courtney M. , Venkat, Puja , Xu, Yaohui , Yu, Siegrid S., McCullough, Beth, Espinosa, Sara, Bordeaux, Jeremy S. , Chen, Pei-Ling , Contreras, Carlo M. , Donigan, Jessica M. , Medina, Theresa Michelle , Nghiem, Paul , Olino, Kelly L. , Park, Soohyung , Sharma, Bhavina, Srivastava, Divya , Yusuf, Mehran Behruj

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 15, 2025 | Volume: 23 | Issue: 1 | Pages: No page available

10.6004/jnccn.2025.0001 | PMID 39819674 Get It

Dermatofibrosarcoma protuberans (DFSP) is a rare cutaneous soft tissue sarcoma and affects an estimated 1,500 people annually in the United States. DFSP frequently exhibits extensive local infiltration. Initial treatment is through surgical excision, and care should be taken to ensure that negative margins are achieved to minimize recurrence. Although DFSP has a reported high rate of recurrence, metastasis is more uncommon. Fibrosarcomatous DFSP is an aggressive variant with an increased risk for local recurrence and metastasis. If achieving negative margins or resection is not feasible, radiation therapy or systemic treatment are options that may be considered by a multidisciplinary team. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) outline recommended treatment options available for DFSP.